Working with companies
We'll work with you to accelerate your projects, helping your cell and gene therapies to be safer, more effective, scalable and affordable.
Our approach

We offer access to our in-house capabilities and infrastructure to companies through projects that are designed to help their technology or therapy succeed. We have experience of delivering projects with companies of different sizes with different needs. We partner with organisations from around the globe to enable their asset to develop into a commercially viable therapy or technology. Our remit, expertise and infrastructure means we can work on any indication or application and our success is based on the ability to move your development forwards.

Commercial readiness advice clinics

Core to our mission is assisting companies to accelerate their product from research status into a viable commercial product. Our commercial readiness advice clinics allow eligible spin-out companies and SMEs to benefit from 12 hours of tailored support in preparation for industrialisation. The commercial readiness advice clinics provide access to CGT Catapult experts from all steps of product development including: process development, clinical, regulatory, health-economics and reimbursement, manufacturing, adoption, as well as grant preparation.

This programme is part funded by the European Regional Development Fund (ERDF).

Discover who we are